This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Zinc supplementation in older patients could help boost their immunity.
The FDA today announced that it's taking a hard look at how it's addressing the opioid abuse epidemic.
A pharmacy robber was found dead in a van just 3 hours after he stole fentanyl.
More than 20,000 articles have been written on how poor medication adherence, which costs the United States between $68 to $146 billion annually, increases adverse clinical outcomes and mortality.
A US Senate committee recently held a hearing to investigate the culprits behind the growing backlog of generic drug applications at the FDA.
The FDA is examining a biologics license application for brodalumab injection 210 mg as a treatment for moderate to severe plaque psoriasis.
Attention-deficit/hyperactivity disorder has long been viewed as a pediatric condition, but it often lasts into adulthood.
With winter well underway, patients may need a refresher on the dangers of double dosing on OTC remedies for their colds and headaches.
The FDA has approved sumatriptan nasal powder for the treatment of migraines with or without aura in adults.
Pharmacists and physicians can now use pharmacogenomic test results to help choose safer and more effective medications for their patients.
Ten percent of individuals worldwide are affected by autoimmune diseases, with systemic lupus erythematosus being one of the most common.
Without proper precautions, the winter months and the frigid temperatures they bring can be dangerous, especially for older adults.
The American Heart Association, the American College of Cardiology, and the American Society of Hypertension recently issued new recommendations for treating hypertension in patients who have been diagnosed with coronary heart disease, stroke, or other forms of heart disease.
Colds are caused by a viral infection in the upper airways, sinuses, throat, and nose.
If all individuals with diabetic retinopathy were treated in a timely manner, the incidence of blindness from diabetes could be decreased by 90%.
Strategic Alliance Partners